We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SXTP icon
3876
60 Degrees Pharmaceuticals
SXTP
$3M
$2.53K ﹤0.01%
+42
New +$2.67K
ACES icon
3877
ALPS Clean Energy ETF
ACES
$123M
-8,304
Closed -$246K
ACMR icon
3878
ACM Research
ACMR
$5.53B
-8,837
Closed -$258K
ACRV icon
3879
Acrivon Therapeutics
ACRV
$74.5M
-10,200
Closed -$72.9K
ADTN icon
3880
Adtran
ADTN
$622M
-31,815
Closed -$173K
AEO icon
3881
American Eagle Outfitters
AEO
$3.07B
-46,011
Closed -$1.19M
AIRS icon
3882
AirSculpt Technologies
AIRS
$194M
-32,000
Closed -$196K
ALG icon
3883
Alamo Group
ALG
$2.06B
-908
Closed -$207K
ALHC icon
3884
Alignment Healthcare
ALHC
$2.86B
-142,827
Closed -$708K
ALTI icon
3885
AlTi Global
ALTI
$476M
-18,000
Closed -$102K
AMD icon
3886
PUT
Advanced Micro Devices
AMD
$767B
-4,100
Closed -$677K
AMSF icon
3887
AMERISAFE
AMSF
$522M
-50,089
Closed -$2.51M
ANDE icon
3888
Andersons Inc
ANDE
$2.23B
-6,704
Closed -$385K
ANIP icon
3889
ANI Pharmaceuticals
ANIP
$1.74B
-7,456
Closed -$515K
BNBX
3890
DELISTED
BNB PLUS CORP
BNBX
-3
Closed -$20.4K
APLT
3891
DELISTED
Applied Therapeutics
APLT
-10,658
Closed -$72.5K
ARM icon
3892
PUT
Arm
ARM
$286B
-400
Closed -$46K
ARTNA icon
3893
Artesian Resources
ARTNA
$357M
-5,824
Closed -$216K
ATRA icon
3894
Atara Biotherapeutics
ATRA
$77.6M
-796
Closed -$13.8K
AU icon
3895
AngloGold Ashanti
AU
$49.2B
-63,241
Closed -$1.4M
AZN icon
3896
PUT
AstraZeneca
AZN
$251B
-10,600
Closed -$1.48M
BA icon
3897
PUT
Boeing
BA
$184B
-100
Closed -$18K
BAR icon
3898
GraniteShares Gold Shares
BAR
$1.48B
-20,200
Closed -$444K
BATT icon
3899
Amplify Lithium & Battery Technology ETF
BATT
$126M
-40,048
Closed -$378K
BCI icon
3900
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.09B
-42,856
Closed -$847K

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.